KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) EBITDA (2016 - 2025)

Historic EBITDA for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $493.0 million.

  • Elevance Health's EBITDA fell 645.16% to $493.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year increase of 697.22%. This contributed to the annual value of $2.2 billion for FY2025, which is 697.22% up from last year.
  • Latest data reveals that Elevance Health reported EBITDA of $493.0 million as of Q4 2025, which was down 645.16% from $625.0 million recorded in Q3 2025.
  • Over the past 5 years, Elevance Health's EBITDA peaked at $625.0 million during Q3 2025, and registered a low of $291.0 million during Q1 2021.
  • For the 5-year period, Elevance Health's EBITDA averaged around $446.6 million, with its median value being $440.5 million (2023).
  • Its EBITDA has fluctuated over the past 5 years, first surged by 60175.44% in 2021, then crashed by 645.16% in 2025.
  • Over the past 5 years, Elevance Health's EBITDA (Quarter) stood at $352.0 million in 2021, then increased by 5.97% to $373.0 million in 2022, then soared by 41.82% to $529.0 million in 2023, then fell by 0.38% to $527.0 million in 2024, then fell by 6.45% to $493.0 million in 2025.
  • Its EBITDA stands at $493.0 million for Q4 2025, versus $625.0 million for Q3 2025 and $486.0 million for Q2 2025.